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Mother-to-child transmission of HIV-1 infection during 
exclusive breastfeeding in the ﬁ rst 6 months of life: 
an intervention cohort study
Hoosen M Coovadia, Nigel C Rollins, Ruth M Bland, Kirsty Little, Anna Coutsoudis, Michael L Bennish, Marie-Louise Newell
Summary
Background Exclusive breastfeeding, though better than other forms of infant feeding and associated with improved 
child survival, is uncommon. We assessed the HIV-1 transmission risks and survival associated with exclusive 
breastfeeding and other types of infant feeding.
Methods 2722 HIV-infected and uninfected pregnant women attending antenatal clinics in KwaZulu Natal, South Africa 
(seven rural, one semiurban, and one urban), were enrolled into a non-randomised intervention cohort study. Infant 
feeding data were obtained every week from mothers, and blood samples from infants were taken monthly at clinics to 
establish HIV infection status. Kaplan-Meier analyses conditional on exclusive breastfeeding were used to estimate 
transmission risks at 6 weeks and 22 weeks of age, and Cox’s proportional hazard was used to quantify associations with 
maternal and infant factors.
Findings 1132 of 1372 (83%) infants born to HIV-infected mothers initiated exclusive breastfeeding from birth. Of 
1276 infants with complete feeding data, median duration of cumulative exclusive breastfeeding was 159 days (ﬁ rst 
quartile [Q1] to third quartile [Q3], 122–174 days). 14·1% (95% CI 12·0–16·4) of exclusively breastfed infants were infected 
with HIV-1 by age 6 weeks and 19·5% (17·0–22·4) by 6 months; risk was signiﬁ cantly associated with maternal CD4-cell 
counts below 200 cells per µL (adjusted hazard ratio [HR] 3·79; 2·35–6·12) and birthweight less than 2500 g (1·81, 
1·07–3·06). Kaplan-Meier estimated risk of acquisition of infection at 6 months of age was 4·04% (2·29–5·76). Breastfed 
infants who also received solids were signiﬁ cantly more likely to acquire infection than were exclusively breastfed 
children (HR 10·87, 1·51–78·00, p=0·018), as were infants who at 12 weeks received both breastmilk and formula milk 
(1·82, 0·98–3·36, p=0·057). Cumulative 3-month mortality in exclusively breastfed infants was 6·1% (4·74–7·92) versus 
15·1% (7·63–28·73) in infants given replacement feeds (HR 2·06, 1·00–4·27, p=0·051).
Interpretation The association between mixed breastfeeding and increased HIV transmission risk, together with evidence 
that exclusive breastfeeding can be successfully supported in HIV-infected women, warrant revision of the present 
UNICEF, WHO, and UNAIDS infant feeding guidelines.
Introduction
Breastfeeding remains an important route of acquisition of 
HIV-1 infection for infants; in 2005, an estimated 
630 000–820 000 infants were newly infected, of whom 
around 280 000–360 000 would have been infected through 
breastfeeding.1–3 Comprehensive prevention of mother-
to-child-transmission (PMTCT) programmes report sub-
stantially lower rates of perinatal transmission of 
between 2% and 5% in non-breastfed and breastfed pop-
ulations.4–6 Yet, even where programmes are available that 
oﬀ er HIV testing to pregnant women and antiretroviral 
prophylaxis for those infected, many infants continue to 
become infected through breastfeeding. National and local 
recommendations for infant feeding by HIV-infected 
mothers in resource-poor countries have been confounded 
by the scarcity of accurate estimates of the risk of HIV 
acquisition through diﬀ erent infant feeding practices and 
the associated survival risks and beneﬁ ts.7 In particular, the 
risks of exclusive breastfeeding by HIV-infected mothers in 
developing countries have not been adequately reported.
Observational data from a randomised trial of the eﬀ ect 
of antenatal vitamin A supplementation on perinatal 
transmission,8 suggested that the risk of postnatal HIV 
transmission was lower with exclusive breastfeeding than 
with mixed breastfeeding. Another trial of a vitamin A 
intervention showed that HIV postnatal transmission risk 
and mortality were higher in mixed breastfed infants than 
in those who were exclusively breastfed.9 Furthermore, both 
clinical trials and operational research settings have shown 
conﬂ icting serious morbidity and mortality risks associated 
with the free provision of replacement feeds.10,11 In 
Botswana, cumulative all-cause infant mortality at 7 months 
was signiﬁ cantly higher in infants randomly assigned to 
formula-feeding than in those assigned to breastfeeding 
and zidovudine.10 In the ﬁ rst quarter of 2006, over 
22 500 infants in 12 districts in Botswana had diarrhoea 
(compared with 9166 in the same period in 2005), and the 
number of deaths in children less than 5 years increased by 
about 20 times; almost all these infants were not breastfed,12 
and there were no reported changes in infant feeding 
practice over this time. In Côte d’Ivoire, however, infants of 
HIV-infected mothers who chose to formula feed had no 
greater mortality than did those who were breastfed.11
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These, and other similar reports, have confused rather 
than guided infant feeding policies and how health workers 
should counsel mothers in high HIV-prevalence settings 
on infant feeding options.13 We therefore implemented a 
study to assess the HIV transmission risks and survival 
associated with exclusive breastfeeding and other types of 
infant feeding.
Methods
Study design
HIV-infected and uninfected pregnant women attending 
antenatal clinics in KwaZulu Natal (seven rural, one 
semiurban, and one urban) were enrolled into a non-
randomised intervention cohort study if they were 
16 years of age or older, planned to stay in the study area 
for at least 3 months after delivery, and provided written 
informed consent. Uninfected women were included to 
establish the eﬀ ect of HIV status on adherence to 
exclusive breastfeeding and other infant-feeding 
practices. The populations served by the rural and 
semiurban antenatal clinics were part of the surveillance 
area of the Africa Centre Demographic Surveillance 
System. Maternal sociodemographic and health 
information was recorded; antenatal CD4-cell counts 
were measured in HIV-infected women (September, 
2001, to March, 2003, FACScan, Becton, Dickinson and 
Company, NJ, USA, thereafter Epics XL, Beckman 
Coulter, CA, USA).
Single-dose nevirapine was provided for all HIV-infected 
women and their infants any time after ﬁ rst booking or 
28 weeks’ gestation.14 All women were counselled 
antenatally about infant-feeding options.15 6 months’ 
supply of commercial infant formula (number of tins 
increased with age) was oﬀ ered free through the KwaZulu 
Natal PMTCT programme from the end of 2002, and 
HIV-infected mothers could choose to access this supply 
any time in the ﬁ rst 12 months of the infant’s life. For 
those initiating formula milk from birth, an initial supply 
was provided antenatally.
After delivery, all mothers, irrespective of HIV status, 
and their infants were visited at home by infant-feeding 
counsellors three or four times in the ﬁ rst 2 weeks of life 
and every 2 weeks thereafter until the infant was 6 months 
old. Counsellors and clinic-based study nurses supported 
mothers to breastfeed exclusively or to replacement feed 
exclusively according to antenatal or present choice. The 
counsellors also recorded information on breast health 
and breastfeeding technique (positioning and attachment) 
but no data on infant-feeding type, to avoid potential 
recording bias. Instead, mothers reported feeding 
practices to an independent group of ﬁ eld monitors who 
visited every week and documented all feeds (milks and 
solids), ﬂ uids, drugs, morbidity episodes, and attendances 
at health facilities for every day of the preceding week. 
Mothers kept food-intake and morbidity diaries for use 
during the ﬁ eld-monitor interview to corroborate the 
verbal report. Cumulative patterns of exclusive breast-
feeding were determined only at the time of analysis and 
not during the course of home visits. If a mother was not 
present for a counselling or monitoring visit, the study 
team returned on up to 2 consecutive days.
Neither feeding counsellors nor ﬁ eld monitors were 
aware of the mothers’ HIV status. Mothers and infants 
also attended clinics 6 weeks after delivery and every month 
thereafter until 6 months. At every visit the study nurse 
measured the infant and recorded any morbidity events, a 
dried blood spot sample was obtained by heel or ﬁ nger 
prick from the infant, and a breastmilk sample from the 
mother. A dried blood spot sample was also obtained 
within 72 h of delivery when possible. Clinic nurses and 
HIV counsellors advised HIV-infected women to stop all 
breastfeeding when infants were 6 months old. At the time 
of the study, highly active antiretro viral treatment was not 
available through the provincial health services. The study 
was approved by the bio medical research ethics committee 
of the University of KwaZulu-Natal.
Exclusive breastfeeding was deﬁ ned as the infant 
receiving only breastmilk from birth (including expressed 
breastmilk) from his or her mother and no other liquids 
or solids, with the exception of drops or syrups consisting 
of vitamins, mineral supplements, or drugs.16,17 Our 
protocol, however, allowed water or formula milk to be 
given for up to a total of 3 days, either on separate or 
continuous days, without exclusion from the group (this 
allowance was included since we were unsure how well 
participants would be able to adhere to the strictest 
deﬁ nition of exclusive breastfeeding). Periods of exclusive 
breastfeeding ended on the fourth day of a child receiving 
either water or formula milk. Infants who received 
porridge or other solid foods, even if only once, were 
excluded from the feeding group. Although the WHO 
deﬁ nition allows all drugs, including those self-prescribed, 
we additionally stipulated that paracetamol could be given 
only for up to 7 days and oral rehydration solution as 
treatment for diarrhoea for up to 72 h. Replacement 
feeding was deﬁ ned as provision of any non-human milk 
and the exclusion of all breastmilk, with or without other 
liquids or solids. Mixed breastfeeding was deﬁ ned as 
giving breastmilk with non-human milk, other liquids, or 
solids.17,18
HIV status was established by quantitative HIV RNA 
assay (Nuclisens HIV-1 QT, Organon Teknika, Boxtel, 
Netherlands, and Nuclisens EasyQ HIV-1, Biomerieux, 
Boxtel, Netherlands) with a sensitivity of 80 copies of HIV 
RNA per mL of blood (equivalent to 1600 copies HIV RNA 
per 50 µL dried blood spot).19 If HIV RNA was not detectable 
(<80 copies per mL blood) the infant was regarded as HIV 
uninfected. Infants were regarded as HIV infected if two 
samples both had more than 4000 copies per mL.20 If the 
second sample had less than 4000 copies per mL, a third 
sample was obtained for conﬁ rmation. For infants with 
detectable HIV RNA viral load at 6 months, stored samples 
were tested, if available, to assess when the infection was 
acquired.
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Statistical methods
We captured data with optical imaging recognition software 
(Teleform, Cardiﬀ , San Diego, CA, USA) into a Microsoft 
SQL Server database with custom written applications 
(Perlcom, Durban, South Africa). Analysis was based on 
the database created on Oct 10, 2005. Infants with no 
feeding or test data were excluded from the analyses, and 
infants were excluded if there were more than 5 days of 
missing feeding data in any 30 day period. Feeding 
categories were established from the analytical database by 
application of algorithms that ﬁ rst classiﬁ ed infant-feeding 
practices on every day of life and then measured the 
cumulative pattern from birth. Analyses were done with 
Stata (version 9.1). Continuous data with a normal 
1449 HIV-infected pregnant women recruited antenatally
1372 HIV-infected mothers with livebirths
1405 infants born live to HIV-infected mothers
1372 singleton, ﬁrst or live twin born to HIV-infected mothers
109 initiated RF
29 switched to RF 101 switched to MBF
28 switched to RF 96 switched to MBF
688 sustained EBF for
at least 14 weeks
14 switched to RF
89 RF at 26 weeks 415 EBF at 26 weeks 434 MBF at 26 weeks
40 switched to MBF
282 MBF at 14 weeks88 RF at 14  weeks
920 sustained EBF for ≥4 weeks
760 had blood sample collected
at 28 days and <56 days
140 had no blood sample
collected, or outside
28–56 days 
76 had blood sample
collected at >28 days and
<56 days
21 had no blood sample
collected, or outside
28–56 days 
126 had blood sample
collected at >28 days and
<56 days
39 had no blood sample
collected, or outside 28–56
days 
All feeding groups—
4 weeks to 14 weeks:
10 moved out of study area
26 withdrew
60 lost to follow-up
43 died
All feeding groups—
birth to 4 weeks:
13 moved out of study area
24 withdrew
32 lost to follow-up
24 died
All feeding groups—
14 weeks to 26 weeks:
9 moved out of study area
10 withdrew
47 lost to follow-up
40 died
72 had blood sample collected
at >20 weeks and <26 weeks
9 had no blood sample
collected, or outside
20–26 weeks
280 had blood sample collected
at >20 weeks and <26 weeks
53 had no blood sample
collected, or outside
20–26 weeks
571 sustained EBF for 20 weeks
497 had blood sample collected
at >20 weeks and <26 weeks
74 had no blood sample collected
or outside 20–26 weeks
35 initiated MBF
1132 initiated EBF
(HIV test results
available for 1034)
96 had no infant-feeding data
12 moved away postnatally
42 withdrew
14 lost to follow-up
28 died soon after birth
36 twin pairs born to HIV infected mothers
4 pairs in which one was stillborn; livebirth included
31 pairs where both were liveborn; second twin excluded
1 pair in which feeding data were missing for ﬁrst twin;
both infants excluded
Figure 1: Flow diagram of infant-feeding groups over time and associated HIV testing
EBF=exclusive breastfeeding. RF=replacement feeding. MBF=mixed breastfeeding. Figure does not show infants who switched from RF (any time) to MBF. MBF 
numbers are included in text and table.
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Overall Exclusive breastfeeding Replacement feeding Mixed breastfeeding Feeding information unavailable p* 
Total 1372 1132 (83%) 109 (8%) 35 (3%) 96 (7%)
Median maternal age (years)† 25·1 (16·1–45·8) 24·9 (16·1–45·8) 27·1 (16·7–41·4) 25·1 (16·3–37·2) 26·0 (18·0–40·0)
Enrolment clinic
Urban 257 (19%) 203 (18%) 35 (32%) 4 (11%) 15 (16%) 0·0003
Semiurban 514 (37%) 414 (37%) 41 (38%) 14 (40%) 45 (47%) 0·8312
Rural 601 (44%) 515 (45%) 33 (30%) 17 (49%) 36 (37%) 0·0023
Highest education attained
None 18 (1%) 10 (1%) 5 (4·6%) 0 3 (3%) 0·0007
Some primary 292 (21%) 230 (20%) 29 (27%) 11 (31%) 22 (23%) 0·1233
7 years (primary) 467 (34%) 392 (35) 35 (32%) 6 (17%) 34 (35%) 0·5954
10 years 328 (24%) 286 (25%) 21 (19%) 7 (20%) 14 (15%) 0·1678
12 years (matriculation) 174 (13%) 138 (12%) 13 (12%) 8 (23%) 15 (16%) 0·9295
Post-matriculation 95 (7%) 76 (7%) 6 (6%) 3 (9%) 8 (8%) 0·6271
House type
Brick 51 (4%) 41 (4%) 6 (6%) 1 (3%) 3  (3%) 0·3259
Concrete/cement/mixed 761 (55%) 637 (56%) 66 (61%) 20 (57%) 38 (40%) 0·3836
Board/mud/sticks/stones 423 (31%) 359 (32%) 27 (25%) 13 (37%) 24 (25%) 0·1366
Unknown/other/missing 137 (10%) 95 (8%) 10 (9%) 1 (3%) 31 (32%) 0·7799
Toilet type
Flush/chemical 249 (18%) 202 (18%) 28 (26%) 4 (11%) 15 (16%) 0·0446
Pit latrine/bucket 792 (58%) 664 (59%) 65 (60%) 23 (66%) 40 (42%) 0·8332
None 289 (21%) 256 (23%) 12 (11%) 7 (20%) 14 (15%) 0·0049
Missing 42 (3%) 10 (1%) 4 (4%) 1 (3%) 27 (28%) 0·0077
Water type
Piped indoors/in yard 536 (39%) 445 (39%) 54 (50%) 10 (29%) 26 (28%) 0·0366
Piped public tap 384 (28%) 319 (28%) 29 (27%) 13 (37%) 23 (24%) 0·7258
Borehole/rain water tank 105 (8%) 91 (8%) 9 (8%) 2 (6%) 3 (3%) 0·9241
River 297 (22%) 260 (23%) 13 (12%) 8 (23%) 16 (17%) 0·0077
Other/missing 50 (4%) 17 (2%) 4 (4%) 2 (6%) 27 (28%) 0·0891
Main income provider
Mother 152 (11%) 117 (10%) 20 (18%) 5 (14%) 10 (10%) 0·0104
Household member at home 842 (61%) 716 (63%) 61 (56%) 23 (66%) 42 (44%) 0·1298
Household member, away, returns <monthly 151 (11%) 123 (11%) 14 (13%) 4 (11%) 10 (10%) 0·5392
Household member, away, returns >monthly 42 (3%) 39 (3%) 2 (2%) 0 1 (1%) 0·3574
Other/missing 185 (13%) 137 (12%) 12 (11%) 3 (9%) 33 (34%) 0·7357
Maternal CD4 cell count (per µL)‡ 453 (2–1835) 462 (21–1835) 395·5 (15–1229) 526 (20–1433) 434 (2–1131)
>500 547 (40%) 465 (41%) 33 (30%) 17 (49%) 32 (33%) 0·0283
200–500 606 (44%) 496 (44%) 48 (44%) 11 (31%) 51 (53%) 0·9711
<200 146 (11%) 111 (10%) 23 (21%) 5 (14%) 7 (7%) 0·0003
Missing 73 (5%) 60 (5%) 5 (5%) 2 (6%) 6 (6%) 0·7541
Maternal mid-upper arm circumference (cm)§ 27 (16–56·4) 27 (16–56·4) 28·1 (21–43) 28·0 (22–38·5) 27·9 (16–37·5)
Infant birthweight (g) 3100 (1150–4600) 3100 (1150–4500) 3200 (1500–4600) 3000 (1600–3800) 3100 (1700–4500)
<2500 138 (10%) 116 (10%) 6 (6%) 7 (20%) 9 (9%) 0·1135
2500–3499 823 (60%) 704 (62%) 67 (62%) 18 (51%) 34 (35%) 0·8872
>3500 301 (22%) 249 (22%) 34 (31%) 5 (14%) 13 (14%) 0·0288
Missing 110 (8%) 63 (6%) 2 (2%) 5 (14%) 40 (42%) 0·0916
Child sex
Male 676 (49%) 571 (50%) 55 (51%) 14 (40%) 36 (38%) 0·9905
Female 671 (49%) 554 (49%) 54 (50%) 21 (60%) 42 (44%) 0·9110
Missing 25 (2%) 7 (1%) 0 0 18 (19%) 0·4097
Data are number (%) or median (minimum, maximum). EBF=exclusive breastfeeding. RF=replacement feeding. *p for comparison between EBF and RF. †n=1368 and 1128 for maternal age groups overall and 
EBF. ‡n=1299, 1072, 104, 33, and 90 for overall, EBF, RF, mixed breastfeeding, and feeding information unavailable, respectively; §n=1068, 931, 88, 29, and 20 for overall, EBF, RF, mixed breastfeeding, and 
feeding information unavailable, respectively.
Table 1: Characteristics for liveborn children and HIV-infected mothers by infant-feeding practice at birth
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distribution were assessed with t test, Mann-Whitney test 
for non-normal distributions, two-sample tests of 
proportions or χ² for categorical variables, and Fisher’s 
exact test if numbers were small.
Cumulative transmission and mortality in the ﬁ rst 
6 months of life were assessed by Kaplan-Meier analysis, 
and association with maternal and infant variables was 
quantiﬁ ed in a Cox regression analysis.21–24 We assessed 
the proportional-hazards assumption of the Cox re-
gression model with log-log plots and regression of the 
Schoenfeld residuals; the goodness-of-ﬁ t was assessed by 
the log-likelihood test.22 Transmission rate at 6 weeks and 
6 months was based on infants’ samples obtained at 
4–8 weeks and 20–26 weeks, respectively.25 For the 
Kaplan-Meier analyses, the estimated time of acquisition 
of infection was taken to be midway between the dates of 
the last negative test and the ﬁ rst positive test.25 For some 
variables, a missing response was considered to mean 
that the interviewee was unsure of the answer, and in 
such cases missing was included as a category of the 
variable. The sample size was deﬁ ned with a CI approach 
on the basis of a priori estimates. We assumed that 6-week 
transmission would be around 11%, and regarded an 
additional 5% postnatal transmission as of public-health 
signiﬁ cance. The sample size to detect whether the 
HIV-infection rate at 22 weeks of infants who were 
exclusively breastfed until 18 weeks was 16% ± 2% variance 
with 80% power and 95% CI (Statcalc in EpiInfo) was 
1344 exclusively breastfeeding mothers, assuming 65% 
exclusive breastfeeding adherence to 18 weeks.
Role of the funding source
The sponsor of the study had no role in study design, data 
collection, data analysis, data interpretation, or writing of 
the report. The corresponding author had full access to all 
the data in the study and had ﬁ nal responsibility for the 
decision to submit for publication.
Results
Between Oct 29, 2001, and April 16, 2005, 2722 women 
delivered 2779 liveborn infants—1372 HIV-infected mothers 
had 1405 infants, 1345 HIV-uninfected had 1369, and ﬁ ve 
had indeterminate HIV-infection status. Our analysis is 
based on HIV-infected mothers and their infants. There 
were 36 twin pairs born to HIV-infected mothers, of whom 
32 were both liveborn, and four in which one of the twins 
was stillborn and one liveborn. Twins were concordant on 
feeding method with the exception of a pair in which 
feeding data were missing for the ﬁ rst born and the second 
born was reportedly exclusively replacement fed. The 
second born of liveborn twins were excluded, leaving 
1372 liveborn infants from 1372 HIV-infected mothers. 
Complete feeding data from birth to 6 months were 
available for 1276 infants. Figure 1 shows recruitment of 
patients, feeding practices, and follow-up, including reasons 
for loss to follow-up and non-availability of infant-feeding 
data and HIV-trans mission results.
Most of the mother-infant pairs initiated exclusive 
breastfeeding (table 1). Median duration of exclusive 
breastfeeding for women who initiated breastfeeding and 
whose infants had HIV test results available (n=1034) was 
159 days (ﬁ rst quartile [Q1] to third quartile [Q3], 
122–174 days); 847 (82%) exclusively breastfed for at least 
6 weeks, 688 (67%) for at least 3 months, and 415 (40%) for 
6 months. The proportions of infants with HIV results 
available who were fed a mixture of breastmilk and other 
ﬂ uids at 6 weeks, 3 months, and 6 months were 3·8%, 
5·7%, and 15·4%, respectively. Some children were 
replacement fed from birth and appropriately switched to 
Maternal antenatal CD4 count by feeding 
method (cells per µL)
HIV point prevalence 
rates
<200 200–500 >500 Missing
EBF (n=362) 30 (8%) 162 (45%) 155 (43%) 15 (4%) 55 (15%; 11·7-19·3)
RF (n=28) 10 (36%) 9 (32%) 8 (29%) 1 (4%) 2* (7%; 0·9–23·5)
MBF (starting <14 weeks; 
n=332)
40 (12%) 159 (48%) 113 (34%) 20 (6%) 89 (27%; 22·1–31·9)
MBF (starting >14 weeks; 
n=239)
30 (13%) 96 (40%) 101 (42%) 12 (5%) 61 (26%; 20·1–31·5)
Data are number (%) or number (%; 95% CI). EBF=exclusively breastfeeding. RF=replacement feeding. MBF=mixed 
breastfeeding. *Two children who switched from EBF to RF.
Table 2: Maternal antenatal CD4-cell counts and HIV point prevalence rates at 26 weeks by method of 
feeding at 26 weeks
Su
rv
iv
al
 p
ro
ba
bi
lit
y
Age (months)
Exclusive breastfeeding (EBF)
Replacement feeding (RF)
Mixed breastfeeding (MBF)
0
0·6
0·7
0·8
0·9
1·0
0 2 3 51 4 6
Children at risk
Overall (1184)
p (survival)
EBF (1034)
p (survival)
RF (101)
p (survival)
MBF (32)
p (survival)
Missing (17)
p (survival)
30 days
980
0·9778
916
0·9796
62
0·9762
5*
0·9545
3
0·6667
60 days
868
0·9568
820
0·9618
46
0·9021
.
.
3
0·6667
90 days
760
0·9309
726
0·9369
33
0·8498
.
.
3
0·6667
120 days
657
0·9128
629
0·9178
28
0·8498
.
.
2
0·6667
150 days
583
0·9027
563
0·9072
21
0·8498
.
.
2
0·6667
180 days
496
0·8728
477
0·8760
18
0·8498
.
.
1   
0·6657
Figure 2: Survival probability by feeding type
*No further events beyond last time point of around 22 days. Note break in legend.
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replacement feeding without any mixed feeding; some 
were not included at some time points because HIV results 
were not available within the interval speciﬁ ed per protocol, 
even though feeding data might have been available. In 
193 076 days of follow-up, exclusive breastfeeding was 
reported in 141 599 (74%) days and complete avoidance of 
breastmilk was reported in 37 143 (19%) days. Of the 
114 women who initiated exclusive breastfeeding and who 
subsequently moved,45 withdrew,35 or were lost-to-follow-
up,34 about 68% were exclusively breastfeeding at the time 
of last contact. More women who chose to replacement 
feed had CD4-cell counts less than 200 cells per µL than 
did those choosing to exclusively breastfeed (p=0·003; 
table 1).
At 4–8 weeks of age (median 44 days; Q1–Q3, 40–48 days), 
998 infants (all feeding types) were tested for HIV infection. 
150 were positive, giving a point prevalence rate of 
15·0% (95% CI 12·9–17·4). At 20–26 weeks of age, 
962 children were tested, of whom 208 (21·6%, 19·1–24·4) 
were infected. Of the 760 exclusively breastfed infants who 
were tested at 4–8 weeks of age, 114 (15·0%, 12·5–17·8)) 
were infected; of the 497 infants exclusively breastfed for 
more than 20 weeks and tested at 20–26 weeks of age, 
80 (16·0%, 13·0–19·6) were infected.
Of 1034 exclusively breastfed infants, 175 had been 
diagnosed with infection before 6 months of age 
(3686·63 person-months at risk postpartum). In Kaplan-
Meier survival analysis conditional on exclusive breast-
feeding, cumulative infection rates were 14·1% (12·0–16·4) 
at 6 weeks of age, 18·1% (15·8–20·8) by 4 months, 
18·6% (16·2–21·4) by 5 months, and 19·5% (17·0–22·4) by 
6 months. In 723 exclusively breastfed infants who were 
HIV uninfected at or after 6 weeks, the estimated 
Kaplan-Meier cumulative risk of infection from 6 weeks of 
age was 1·1% (0·28–1·84) after 1 month, 2·2% (1·05–3·34) 
after 2 months, 2·7% (1·44–4·02) after 3 months, 
3·3% (1·88–4·77) after 4 months, and 4·0% (2·29–5·76) 
after 5 months (ie, at about 6 months of age).
For infants who were HIV uninfected at or after 6 weeks 
of age, and accounting for a 2-week time lag between the 
end of a feeding episode and the estimated time of 
infection, the overall transmission rate per 100 child-days, 
including infants who were replacement fed and those 
with missing data excluded, was 0·032 (0·0222–0·0455). 
This rate varied from 0·0290 (0·0195–0·0442) for 
100 days of exposure to exclusive breastfeeding and 
0·0436 (0·0208–0·0915) for breastmilk plus other foods or 
ﬂ uids. This result equates to an estimated risk of 10·72 per 
100 child-years of exposure to exclusive breastfeeding (or 
0·89% per child-month). In Cox regression analysis with 
exclusive breastfeeding as reference, the hazard ratio (HR) 
for breastmilk plus other food or ﬂ uids was 1·56 (0·66–3·69, 
p=0·308).
Infants who were breastfed but also received solids 
(generally home-prepared cereal or commercial infant 
porridges) any time after birth, were nearly 11 times 
more likely to acquire infection than were exclusively 
breastfed children (HR 10·87, 1·51–78·00, p=0·018). 
203 mothers started exclusively breastfeeding and later 
introduced solids; the median age at which solids were 
introduced was 147 days (Q1–Q3, 99–171 days). Similarly, 
infants who at 14 weeks of age were fed both breastmilk 
and formula milk were nearly twice as likely to be 
infected as exclusively breastfed infants at that time 
(1·82, 0·98–3·36, p=0·057). Table 2 shows maternal 
antenatal CD4-cell counts and HIV point prevalence 
rates at 26 weeks of age by method of feeding at 
26 weeks.
In a further regression analysis with feeding classiﬁ ed as 
exclusive breastfeeding for 20 weeks or more, exclusive 
replacement feeding for 6 months, or mixed breastfeeding 
starting before 3 months and after 3 months, both 
early-mixed feeders (n=356) and late-mixed feeders (n=257) 
were at greater risk of being infected than were infants 
exclusively breastfed (1·54, 1·10–2·15, p=0·011 and 1·53, 
1·07–2·20, p=0·021, respectively).
94 of the 1034 liveborn children who were initially 
exclusively breastfed died, with estimated cumulative 
mortality rates increasing from 1·92% (1·23–3·00) after 
1 month, 3·60% (2·66–5·10) at 2 months, 6·13% 
(4·74–7·92) at 3 months, 8·01% (6·37–10·05) at 
4 months, 9·20% (7·27–11·22) at 5 months, and 12·24% 
(10·06–14·85) at 6 months. Of these 94 infants who 
died, 73 (78%) were HIV infected. Eight of 101 children 
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Figure 3: 6 month HIV-free survival by feeding type
*No further events beyond last time point of around 22 days. Note break in legend.
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who initiated exclusive replacement feeding from birth 
died. Kaplan-Meier mortality estimates by the end of 
1 month were 4·22% (1·34–12·87), 9·90% (4·49–21·05) 
after 2 months, and 15·12% (7·63–28·73) after 3 months 
with no further events thereafter (ﬁ gure 2). In a separate 
Cox regression model including both exclusive 
breastfeeding and replacement feeding, the HR for 
formula feeding was 2·06 (1·00–4·27, p=0·051). Overall, 
there were 223 (22%) deaths or infections in infants 
exclusively breastfed, resulting in an overall Kaplan-
Meier estimated HIV-free survival of 75·4% at 6 months 
(ﬁ gure 3).
In univariable and multivariable Cox’s regression 
analyses conditional on exclusive breastfeeding, risk of 
transmission overall was strongly associated with maternal 
CD4-cell counts and less strongly with maternal age, 
birthweight below 2500 g, vaginal delivery, and long 
duration of ruptured membranes (table 3). The estimated 
transmission at 6 months in exclusively breastfed infants 
born to HIV-infected women with CD4-cell counts less 
than 200 per µL or 200 and greater cells per µL were 34% 
and 17%, respectively. Infant’s sex, maternal socio-
economic status and education, location of residence, 
antenatal feeding intention, and duration of labour were 
not signiﬁ cantly associated with the overall risk of 
transmission, and there was no evidence of a signiﬁ cant 
trend over time. Data for nevirapine uptake and ingestion 
were inconsistent and are not included in any analysis.
In univariable regression analyses, maternal CD4-cell 
count (less than 500 per µL), low birthweight, infant’s 
infection status, and place of birth (other or unknown) 
were signiﬁ cantly associated with increased mortality. In 
multivariable analyses, however, only infant’s infection 
status was signiﬁ cantly associated with death; infected 
infants were 15 times more likely to die than uninfected 
children (15·28, 9·20–25·40, p<0·0001). In multivariable 
analyses, in a model with a signiﬁ cantly reduced 
goodness-of-ﬁ t (log likelihood –599·07 compared with 
–530·11) that excluded infant’s infection status, the only 
signiﬁ cant factor was maternal CD4-cell count. Infants 
born to mothers with a CD4-cell count of 200–500 cells 
per µL were nearly twice as likely to have died (unadjusted 
HR 1·89, 1·16–3·08, p=0·011) than were those born to 
mothers with a CD4-cell count greater than 500 per µL. 
Those born to mothers with CD4-cell counts less than 
200 per µL were more than three times as likely to have 
died (3·19, 1·73–5·88, p=0·0001).
Infants born to mothers with CD4-cell counts less 
than 200 per µL were almost four times more likely to 
acquire HIV or die than were those born to mothers 
with CD4-cell counts greater than 500 per µL, and those 
born to mothers with CD4-cell counts between 200 and 
500 cells per µL were 2·2 times more likely to acquire 
HIV or die. Other variables signiﬁ cantly associated with 
decreased HIV-free survival were birthweight less than 
2500 g, rupture of membranes for longer than 12 h, and 
maternal age between 20 and 30 years (table 4).
Discussion
This study, with a rigorous design and implementation, 
accords with earlier reports that exclusive breastfeeding 
carries a signiﬁ cantly lower risk of HIV transmission than 
do all types of mixed breastfeeding.8,9  Infants who received 
formula milk in addition to breastmilk, before or after 
14 weeks of age, were nearly twice as likely to be infected as 
were infants who received breastmilk only. Although the 
numbers in non-exclusively breastfeeding categories were 
small, infants who were breastfed but also received solids 
were nearly 11 times more likely to acquire HIV infection 
than were those who received breastmilk only.
The main objective of our study was to provide an 
accurate rate of mother-to-child transmission of HIV-1 and 
survival of exclusively breastfed infants born to women 
who were HIV infected at enrolment. We initiated an 
intervention cohort study that oﬀ ered intensive 
infant-feeding support and ensured high-quality data 
through carefully designed data-collection forms and 
processes. We did not randomly assign infants to the 
diﬀ erent feeding groups for several reasons. We already 
knew that there is no transmission after 6 weeks (beyond 
perinatal acquisition) if mothers do not breastfeed, 
n Hazard ratio 
(95% CI)
p Adjusted hazard 
ratio* (95% CI)
p
Maternal age (years)
<20 162 1·0
20–30 634 1·94 (1·17-3·23) 0·010 1·86 (1·11–3·11) 0·018
>30 234 1·42 (0·79-2·54) 0·239 1·25 (0·69–2·25) 0·466
Missing 4 3·21 (0·43-24·10) 0·258 2·23 (0·29–17·1) 0·437
Maternal CD4-cell count per µL
>500 412 1·0 1·0
200–500 463 2·43 (1·66- 3·55) <0·001 2·44 (1·67– 3·58) <0·001
<200 106 3·90 (2·43- 6·26) <0·001 3·79 (2·35– 6·12) <0·001
Missing 53 2·72 (1·42- 5·22) 0·003 3·04 (1·58– 5·86) 0·001
Birthweight (g)
Over 3500 229 1·0 1·0
2500–3500 649 1·12 (0·75-1·65) 0·584 1·07 (0·72–1·59) 0·748
Below 2500 108 2·10 (1·27-3·48) 0·004 1·81 (1·07–3·06) 0·026
Missing 48 1·63 (0·82-3·21) 0·164 1·10 (0·51–2·36) 0·803
Duration of rupture of membranes (h)
<4 558 1·0 1·0
4–12 125 0·63 (0·36-1·11) 0·107 0·68 (0·39–1·20) 0·181
>12 55 2·04 (1·22-3·43) 0·007 2·19 (1·29–3·70) 0·004
Missing 296 1·13 (0·81-1·59) 0·474 1·19 (0·84–1·68) 0·324
Method of delivery
Vaginal 901 1·0 1·0
Caesarean section 133 0·56 (0·32-0·97) 0·037 0·51 (0·29–0·90) 0·019
Place of delivery
Hospital or clinic 865 1·0 1·0
Home and other 149 1·49 (1·03-2·18) 0·037 1·29 (0·86–1·97) 0·220 
Missing 20 2·35 (1·04-5·33) 0·041 2·04(0·85–4·90) 0·110 
*Adjusted for all variables in the table.
Table 3: Mother-to-child transmission risk during exclusive breastfeeding (n=1034)
Articles
1114 www.thelancet.com   Vol 369   March 31, 2007
although many mothers who choose replacement feeding 
also breastfeed for various reasons.3 Most importantly, we 
believed a randomised study would be unethical because 
of the well-documented morbidity and mortality risks of 
mixed breastfeeding. We expected, however, that some 
women would choose replacement feeding whereas others 
would default to mixed breastfeeding, allowing some 
comparative analyses. Most women sustained exclusive 
breastfeeding for long periods, resulting in very few infants 
being mixed fed, and thus our ability to make comparative 
analyses was restricted. Our study design contrasts with 
the two studies in South Africa and Zimbabwe that 
examined infant feeding and HIV transmission, in which 
only 26% and 8% of infants, respectively, were still 
exclusively breastfed at 3 months.9,26
Our results show that the Kaplan-Meier estimated risk of 
postnatal transmission of HIV by 20–26 weeks of age in 
exclusively breastfed infants who were negative at 6 weeks 
of age was 4·04%. This result is close to that of the Durban 
(South Africa) study, in which the cumulative probability 
of infection between 6 weeks and 6 months in the 
118 infants who were exclusively breastfed for at least 
3 months was 4·4%.26 In the Harare (Zimbabwe) study the 
estimated risk of transmission in 156 infants who were 
exclusively breastfed for at least 3 months was only 
1·3% compared with 3·9% in the entire cohort (n=2060) 
and 4·4% in infants who received mixed feeding.9
Methodological diﬀ erences and the heterogeneity in risk 
factors for transmission and survival,25 and diﬀ erences in 
overall rates3,27,28 make direct comparisons diﬃ  cult. The 
Durban and Harare studies were both randomised 
controlled trials of the eﬀ ect of vitamin A supplementation 
on mother-to-child transmission. Estimation of the risk of 
HIV transmission associated with exclusive breastfeeding 
was a secondary objective, and infant-feeding data were 
obtained only at 6 weeks, 3 months, and 6 months. The 
long recall periods could have caused misclassiﬁ cation of 
feeding type.29 Conversely, the frequent visits made by 
feeding counsellors in our study might have prompted 
mothers to report feeding practices falsely and over-
represent exclusive breastfeeding. However, feeding 
information in this study was obtained by a separate team 
of ﬁ eldworkers who were unaware of the feeding 
counsellors’ interactions with mothers. The Durban and 
Harare studies were urban-based studies and had 
substantially fewer infants exclusively breastfeeding 
beyond 3 months than in our study. Clade C, the dominant 
HIV type found in South Africa, is more likely to result in 
mother-to-child transmission than in clades A and B found 
elsewhere in Africa.30–32
We implemented an intervention to improve exclusive 
breastfeeding practices in HIV-infected women who chose 
to breastfeed and in HIV-uninfected women. We achieved 
a much higher rate of exclusive breastfeeding than has 
previously been reported in any HIV-infected or 
HIV-uninfected cohorts using the most stringent of 
deﬁ nitions and data-collection methods. In our experience, 
HIV-infected women, if given good support, are able to 
adopt appropriate and optimum feeding practices, 
including rapid cessation at 6 months (data not reported) 
to restrict both transmission and mortality risks present in 
the environment. Although many infants were withdrawn 
from the study and HIV test results were unavailable for 
some, their omission is unlikely to signiﬁ cantly aﬀ ect the 
transmission risks and estimates. Feeding practices in 
these infants were very similar to those in their peers at the 
time of withdrawal or loss to follow-up, and demographic 
determinants such as maternal socioeconomic status and 
education and location of residence were not otherwise 
associated with transmission risks. Infant’s sex did not 
aﬀ ect either feeding practices or, in contrast with other 
studies,27 the rate of postnatal transmission.
Exclusive breastfeeding ordinarily protects the integrity 
of the intestinal mucosa, which thereby presents a more 
eﬀ ective barrier to HIV. Exclusive breastfeeding is also 
associated with fewer breast health problems than is mixed 
feeding, such as subclinical mastitis and breast abscesses, 
which in turn are associated with increased breastmilk 
viral load. The eﬀ ect that small departures from exclusive 
breastfeeding have on the risk of HIV transmission is 
uncertain, although predominant breastfeeding (the 
introduction of non-milk ﬂ uids) was associated with 
reduced transmission in one study.9 Why is the addition of 
solids especially hazardous? Perhaps large and complex 
n Hazard ratio 
(95% CI)
p Adjusted hazard 
ratio* (95% CI)
p
Maternal age (years)
<20 162 1·0
20–<30 634 1·58 (1·04–2·40) 0·031 1·54 (1·01–2·35) 0·043
30+ 234 1·19 (0·73–1·93) 0·479 1·10 (0·67–1·79) 0·714
Missing 4 2·15 (0·29–15·88) 0·451 1·35 (0·18–10·03) 0·772
Maternal CD4 cell count  per µL
>500 412 1·0 1·0
200–500 463 2·25 (1·61– 3·13) <0·001 2·28 (1·63– 3·18) <0·001
<200 106 4·02 (2·68– 6·02) <0·001 3·97 (2·63– 5·98) <0·001
Missing 53 2·05 (1·09– 3·85) 0·026 2·25 (1·19– 4·24) 0·012
Birthweight (g)
Over 3500 229 1·0 1·0
2500–3500 649 1·22 (0·86–1·73) 0·273 1·16 (0·81–1·65) 0·421
Below 2500 108 2·17 (1·38–3·42) 0·001 1·93 (1·21–3·05) 0·005
Missing 48 1·34 (0·69–2·62) 0·387 1·14 (0·58–2·25) 0·697
Duration of rupture of membranes (h)
Less than 4 558 1·0 1·0
4–12 125 0·81 (0·51–1·28) 0·362 0·88 (0·56–1·40) 0·539
>12 55 2·11 (1·33–3·38) 0·002 2·32 (1·44–3·72) 0·001
Missing 296 1·22 (0·90–1·65) 0·190 1·29 (0·95–1·75) 0·104
Method of delivery
Vaginal 901 1·0 1·0
Caesarean section 133 0·60 (0·37–0·95) 0·031 0·50 (0·31–0·81) 0·005
*Adjusted for all variables in the table
Table 4: Factors associated with HIV-free survival in exclusively breastfed infants in the ﬁ rst 6 months of 
life (n=1034)
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proteins found in solid foods precipitate greater damage 
than do modiﬁ ed cows’ milk proteins to gastrointestinal 
mucosa, which ease viral entry between cells, or regulate 
gut receptors diﬀ erently, thereby increasing the likelihood 
of virus adherence and infection. Smith and Kuhn33 have 
summarised some of these ﬁ ndings and mechanisms.
We noted that mortality in the ﬁ rst 3 months of life was 
roughly doubled in the group receiving replacement 
feeding compared with the exclusive breastfeeding group 
(15% vs 6%). This result remains a concern, even though 
mothers who chose to replacement feed were more likely 
to have CD4-cell counts less than 200 per µL than were 
mothers who exclusively breastfed. If these women also 
had clinical symptoms, their ability to care for their 
children appropriately could have been aﬀ ected. A 
signiﬁ cant increase in early mortality in formula fed versus 
breastfed infants was also identiﬁ ed in studies in Kenya34 
(11% vs 9%) and Botswana35 (7·6% vs 3·7%). However, in 
better resourced areas these diﬀ erences have not been 
reported,36 which reinforces the UNAIDS guidelines on 
replacement feeding—namely, “where replacement 
feeding is acceptable, feasible, aﬀ ordable, sustainable, and 
safe, avoidance of all breastfeeding is recommended, 
otherwise exclusive breastfeeding is recommended for the 
ﬁ rst few months of life”.37
The substantial mortality associated with not 
breastfeeding in this study emphasises the importance of 
developing feeding policies appropriate to background 
infant-mortality rates, which can be successfully supported 
by health services and to guide individual mothers. 
The Lancet series38 on global dimensions of neonatal and 
child survival emphasised the need to consider overall 
survival and not only avoidance of HIV infection; 
breastfeeding remains a key intervention to reduce 
mortality. Even in countries with high HIV prevalence, 
breastfeeding could prevent 13% of deaths in children 
younger than 5 years; in countries with low HIV prevalence, 
15% of under-5 deaths could be prevented. Furthermore, 
210 000–270 000 of new infections attributable to breast-
feeding every year could be averted if HIV-infected mothers 
who breastfeed stopped after 6 months of exclusive 
breastfeeding (around 4% transmission) rather than 
the more usual 18–24 months of mixed feeding 
(16% transmission). This ﬁ nding also has relevance for the 
promotion of exclusive breastfeeding in HIV-uninfected 
mothers in high-prevalence settings; in addition to the 
proven survival beneﬁ ts for the infant, if such mothers 
unknowingly become HIV infected while breastfeeding, 
exclusive breastfeeding will carry a lower risk of 
transmission than will mixed breastfeeding.
Infants exclusively breastfed by women with CD4-cell 
counts less than 200 per µL were twice as likely to become 
infected and almost four times more likely to die before 
6 months of age than were infants exclusively breastfed by 
women with CD4-cell counts above 500 per µL. Similar 
ﬁ ndings in west,39 east,27,40 and southern Africa9 provide a 
strong argument for intensiﬁ cation of eﬀ orts to identify 
this susceptible group and immediately oﬀ er them highly 
active antiretroviral treatment for the health of both 
mothers and infants. Where such programmes exist, the 
referral and counselling of pregnant women and initiation 
of treatment should be an over-riding priority that is closely 
monitored as an indicator of overall programme 
eﬀ ectiveness.
The key policy ﬁ nding of our study is the deﬁ nite 
demonstration that early introduction of solid foods and 
animal milks increases HIV transmission risks compared 
with exclusive breastfeeding from birth. These data, 
together with evidence that exclusive breastfeeding can be 
supported in HIV-infected women, warrant revision of the 
present UNICEF, WHO, and UNAIDS infant feeding-
guidelines that were last revised in 2000.37 The need for 
this review is reinforced by the reported drawbacks of free 
formula milk41,42 and WHO recommendations for the 
provision of highly active antiretroviral therapy to pregnant 
women with CD4-cell counts lower than 200 per µL.43
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